Giving a Voice to the Silent Stigma: ED and Men's Sexual Health - A Not for Men Only Conversation sponsored by Charlesseminars.com
When an estimated 1 billion viewers worldwide sit down to watch Super Bowl XXXIX this Sunday, February 6th, there will be a silent elephant in living rooms around the world: Erectile Dysfunction. Help is on the way.
(PRWEB) February 4, 2005 -- When an estimated 1 billion viewers worldwide sit
down to watch Super Bowl XXXIX this Sunday, February 6th, there will be a silent
elephant in living rooms around the world: Erectile Dysfunction.
While
not expected to be present in the stadium in Jacksonville, FL after the Levitra
Play of the Year is announced, the impact of LevitraÒ’s 3 year sponsorship of
the NFL regular season, which ends March 2006, will be felt long after the Super
Bowl airs.
Through it's sponsorship of the regular season of the
National Football League, Levitra a prescription drug for ED from Bayer
Pharmaceuticals, has been a gentle reminder each week that ED is a common,
treatable condition that impacts men and their partners’ daily. Estimates run as
high as 32 million men may have some level of ED--the inability to achieve or
maintain an erection through to satisfaction.
In fact, as couples gather
around the television this Sunday, estimates are that 1 in 10, if not 1 in 4
relationships are impacted by ED.
Has FDA approval for prescription drugs
for ED, such as Viagra from Pfizer, Inc in 1998, Levitra from Bayer
Pharmaceuticals in 2003 and Cialis in November, 2003 opened the door to
communication about this common occurrence? Maybe not as much as was first hoped
for by the Pharmaceutical companies. The America Foundation for Urologic Disease
reports only about 10% of men suffering from ED seeks treatment. This is in
spite of over $200 million in advertisements between ads for Viagra and Levitra
combined. (WSJ 1/13/2005)
One of the problems facing couples is that not
all men can take these prescription medications for other health reasons. The
FDA also reports that some alternative remedies sold over the Internet are as
dangerous to some men as the prescription products. None-the-less, National
Health Expert, Dr. Eugene Charles, DC, DIBAK, feels that all the publicity has
been good for men's sexual health overall. "Awareness is the first step to
increased power", pg 289 from his book, The Day Society Found Her Soul.
"The next step is understanding all your options. While pharmaceuticals
may have their place, there are some natural options that pose no health risks
that should also be explored. Talking about this intimate issue is an important
step and women can help their man out by getting all the facts," said Dr.
Charles. "While it isn't discussed this way, when a man is impacted, so is his
partner. ED is an issue for couples to solve together." To aid in this
communication, Dr. Charles is holding a free teleseminar, sponsored by
Charlesseminars.com, on Wednesday, February 16, 2005 at 6pm PST/9pm Eastern
Time. The teleseminar is open to both men and women who want to learn more about
solutions to ED and improving men's sexual health with natural options.
To register for this important, complimentary educational teleseminar
and to download Dr. Charles' Special Report, 5 Steps to Improve Men's Sexual
Health, please go to www.charlesseminars.com or call 1-800-351-5450. This
Teleseminar is independent of sponsorship of any medications mentioned and no
endorsement is intended, either expressed or implied.
Dr. Eugene Charles,
DC DIBAK is a National Health Expert on natural healing therapies and
treatments. A Diplomate in Applied Kinesiology,
Dr. Charles has been treating
patients for over 18 years in Manhattan. Founder of The Charles Institute, Dr.
Charles trains medical doctors, chiropractors and other diagnosticians in the
healing treatments of Applied Kinesiology and has a national referral network of
trained health practitioners.
For Radio and Television interviews or
speaking engagements, please contact Maureen O'Crean, Los Angeles based
publicist at 310-379-9620.
# # #
Source : http://www.prweb.com/releases/2005/2/prweb204892.htm